Abbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.
The mainstream news isn't breathing a word about it… … but the government is about to unleash a shocking change to bank accounts in the United States. It's going to rip away your privacy and control of your savings. From Investor Place Media.
For months I've been warning about the federal government's terrifying new program to control every American's bank account. It gives them the power to monitor every single transaction … From Weiss Ratings.
I will say this much: After 20 years on Wall Street, I've never seen anything make as much money in unstable markets as this strategy. From Quick Income Trader.
UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. From Behind the Markets.
Tom Busby is about to release his next Weekend Trade. If you're reading this, that means you're late… But not too late! There is still time to tap into this unique income opportunity before the weekend rolls around! From DTI.
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. From Crypto Swap Profits.
Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO's, CFO's, COO's and other insiders.
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
Post a Comment
Post a Comment